- Home
- FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose, w/o L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose, w/o L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ DCP-DMEML-QB1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) Dulbecco's Modified Eagle Medium, Low Glucose formulation, engineered for microphysiological systems (MPS), organ-on-a-chip (OoC), and microfluidic tissue models. The quadruple-stage filtration train reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used in conventional single-stage filtration — supporting unobstructed microchannel flow and low-particulate optical baselines. This formulation is prepared without L-glutamine or sodium bicarbonate, giving researchers independent control of nitrogen supplementation and buffering chemistry for CO2-independent or custom-buffered culture systems.
- Quadruple-stage filtration train: 0.1 µm → 0.04 µm → 0.1 µm → 0.04 µm, reaching a 0.04 µm final cut-off
- Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), tested per manufacturing batch
- Low Glucose (1.0 g/L) base with 110 mg/L sodium pyruvate; formulated without L-glutamine (add fresh at time of use) and without sodium bicarbonate
- Contains phenol red (15.9 mg/L) as a pH indicator — orange-colored, clear solution
- Bicarbonate-free formulation intended for CO2-independent or user-buffered culture systems (e.g., HEPES-supplemented)
- Manufactured under an ISO 13485:2016 quality management system with full lot traceability; final QC and packaging at Diagnocine, Totowa, NJ
- 4× Basal Medium Eagle (BME) amino acid and vitamin concentrations; 31 total components across inorganic salts, amino acids, vitamins, and other constituents
- Custom pH, glucose concentration, salts, and nutrient adjustments available on request
- Glucose1000 mg/L (1.0 g/L, Low Glucose)
- L-GlutamineNot included
- Sodium Pyruvate110 mg/L
- pH (USP <791>)7.4
- Osmolality (USP <785>)230–270 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack (temperature-controlled)
Engineered where standard media fails
Conventional 0.22 µm–filtered DMEM passes mycoplasma (0.2–0.3 µm diameter) and subvisible particulates that accumulate inside microfluidic channels, foul chip geometries, and add background noise to optical and sensor measurements. FluxMPS™ is designed specifically for these failure modes.
Microchannel-safe purity
0.04 µm final filtration removes sub-micron particulates that can foul channels below 100 µm. USP <788> Method 1 (light obscuration) particulate testing supports safe perfusion across a wide range of chip geometries.
Total metabolic control
A defined Low Glucose (1.0 g/L) base with 110 mg/L sodium pyruvate and no added L-glutamine or sodium bicarbonate lets researchers set the carbon source, nitrogen source, and buffering chemistry independently for Warburg-effect and metabolic flux studies.
Ultrapure-grade water
Every batch is prepared using Ultrapure Type 1 water (18.2 MΩ·cm, ASTM D1193 / ISO 3696), manufactured under trace-metal and total organic carbon (TOC) control to minimize background contaminants.
Low background for imaging
Ultra-low particulate count from quadruple-stage filtration reduces particulate-driven background in confocal, widefield, and biosensor measurements on chip. This formulation contains phenol red (15.9 mg/L), which contributes its own optical absorbance; a phenol red–free variant is available on request for fluorescence-sensitive assays.
Rich, stable nutrient profile
4× Basal Medium Eagle (BME) amino acid and vitamin concentrations, micro-batch manufacturing, and per-lot QC support reproducible cell growth across multi-day perfusion experiments.
Customization on demand
pH, glucose concentration, salts, HEPES, and nutrient composition are adjustable per your protocol. Contact support@diagnocine.com to specify your formulation.
Quadruple-stage filtration system
A validated four-stage filtration train reaches a final 0.04 µm pore size under controlled aseptic fill conditions. Each 0.04 µm final filter is protected by its own dedicated 0.1 µm prefilter, giving two complete prefilter + final-filter pairs in series.
-
1
0.1 µm Prefiltration I
Removes large aggregates, cell debris, and process contaminants. Protects the first 0.04 µm cartridge from early fouling.
-
2
0.04 µm Final filtration I
Retains fine particulates and material in the mycoplasma size range (0.2–0.3 µm) — a step absent from standard 0.22 µm filtration.
-
3
0.1 µm Prefiltration II
A second dedicated prefilter protecting the second 0.04 µm cartridge, providing redundancy across the full train.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter ahead of aseptic fill and finish in a validated ISO Class 5 (Class 100) laminar-flow workstation.
Performance vs. conventional media
The quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration — addressing microchannel fouling and mycoplasma-size particulates that pass standard single-stage filtration.
pore size — five times finer
than standard 0.22 µm media
(0.1 µm ×2 + 0.04 µm ×2)
© Diagnocine® — DCP-DMEML-QB1X
Designed for next-generation cell models
FluxMPS™ DCP-DMEML-QB1X supports demanding cell culture platforms — from single-channel microfluidic chips to multi-organ body-on-a-chip systems — where media purity, metabolic precision, and buffering flexibility matter.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) MPS Grade variant is available on request for automated bioreactor perfusion systems, robotic liquid handlers, and long-duration closed-loop platforms where even trace particulates cause valve failure or sensor drift.
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates invisible to standard QC methods
- Valve & Sensor Protection: Reduces micro-fouling of solenoid valves, peristaltic pump tubing, and inline optical sensors
- Extended Perfusion Stability: Supports consistent nutrient delivery over weeks-long culture without filter replacement in the chip circuit
Inquiry Required: The 0.01 µm MPS Grade is a separate, custom product. Contact support@diagnocine.com to request this variant.
Micro Physiological System (MPS) & Chip
Ultra-clean, 0.04 µm–filtered media supports unobstructed microchannel flow and laminar flow fidelity in complex multi-organ chip architectures.
Warburg Effect & Metabolic Research
Low glucose (1.0 g/L) base with user-defined nitrogen sources supports precise control of aerobic glycolysis for Warburg phenotype studies.
iPSC-Derived Models
Ultra-low endotoxin (< 0.05 EU/mL release specification) and mycoplasma-retentive filtration support sensitive iPSC-differentiation protocols.
Endothelial & Primary Cells
Particle-reduced, endotoxin-controlled DMEM supports HUVEC and primary hepatocyte monolayer culture for barrier-function assays and TEER monitoring.
Metabolic Flux Analysis
Defined low-glucose formulation with omitted glutamine provides a controlled metabolic background for 13C isotope tracing and extracellular flux measurement. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red–free medium; this formulation contains phenol red.
Microscopy & Optical Sensing
Ultra-low particulate count from quadruple-stage filtration reduces particulate background for confocal, widefield, and biosensor measurements on chip. Request the phenol red–free variant for fluorescence-sensitive imaging assays.
Analytical release specifications
Every batch is released against the full specification matrix below. CoA available on request: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose (Low), [+] Sodium Pyruvate | [-] L-Glutamine, [-] Sodium Bicarbonate |
| Appearance | Orange-colored, clear solution (phenol red present) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 230–270 mOsm/kg H2O |
| Glucose | 1000 mg/L (1.0 g/L, Low Glucose) |
| L-Glutamine | Not included |
| Sodium Pyruvate | 110 mg/L |
| Phenol Red | 15.900 mg/L |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Ultrapure Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | Bicarbonate-free formulation; CO2-independent when buffered (e.g., 10–25 mM HEPES added by user); validate per cell line and culture system |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
FluxMPS™ DMEM is a modification of Basal Medium Eagle (BME) containing 4× BME concentrations of amino acids and vitamins, plus glycine, serine, and ferric nitrate. Total ingredients: 31 across four formulation categories (Inorganic Salts, Amino Acids, Vitamins, Others), organized into three tabs below. Every ingredient listed is present in the released product; CAS numbers provided for traceability.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 30.000 |
| L-Arginine hydrochloride | 1119-34-2 | 84.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 62.570 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 105.000 |
| L-Leucine | 61-90-5 | 105.000 |
| L-Lysine hydrochloride | 657-27-2 | 146.000 |
| L-Methionine | 63-68-3 | 30.000 |
| L-Phenylalanine | 63-91-2 | 66.000 |
| L-Serine | 56-45-1 | 42.000 |
| L-Threonine | 72-19-5 | 95.000 |
| L-Tryptophan | 73-22-3 | 16.000 |
| L-Tyrosine Disodium Salt dihydrate | 69847-15-0 | 103.790 |
| L-Valine | 72-18-4 | 94.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 4.000 |
| D-Ca-Pantothenate | 137-08-6 | 4.000 |
| Folic acid | 59-30-3 | 4.000 |
| Nicotinamide | 98-92-0 | 4.000 |
| Pyridoxal hydrochloride | 65-22-5 | 4.000 |
| Riboflavin | 83-88-5 | 0.400 |
| Thiamine hydrochloride | 67-03-8 | 4.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 7.200 |
| D-Glucose | 50-99-7 | 1000.000 |
| Phenol red sodium salt | 34487-61-1 | 15.900 |
| Sodium pyruvate | 113-24-6 | 110.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system spanning raw materials, in-process controls, and final-product testing.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016-certified quality management system. Final packaging, QA, and testing are conducted at the Diagnocine R&D and Quality Testing Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
All formulations use Ultrapure Type 1 water (18.2 MΩ·cm, ASTM D1193 / ISO 3696), manufactured under trace-metal and total organic carbon (TOC) control.
ISO Class 5 Fill & Finish
Final aseptic fill performed in a validated ISO Class 5 (Class 100) laminar-flow workstation, supporting container-closure integrity at the point of fill.
Micro-Batch Precision
Small-batch production with full per-lot traceability. Each batch is individually tested and released; a Certificate of Analysis is issued for every batch.
Endotoxin — USP <85> BET
Limulus Amebocyte Lysate (LAL) assay; assay sensitivity 0.005 EU/mL. Release specification: < 0.05 EU/mL, tested per manufacturing batch.
Particulate — USP <788> Method 1
Light obscuration particle count. Release limits: NMT 25/mL (≥10 µm) and NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Freezing-point osmometry. Target range: 230–270 mOsm/kg H2O.
Documentation & CoA
Full Certificate of Analysis with raw-material traceability, in-process records, and final-release test results available for every batch upon request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-DMEML-QB1X compares
FluxMPS™ DCP-DMEML-QB1X vs. conventional 0.22 µm–filtered DMEM formulations.
| Parameter | DCP-DMEML-QB1X (FluxMPS™) | Conventional DMEM (0.22 µm filtered) |
Standard Alt. DMEM (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Standard (0.22 µm filtered) | Standard (0.22 µm filtered) |
| No L-Glutamine, no Sodium Bicarbonate — supports CO2-independent, user-buffered microfluidic culture | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple-stage) | 1 | 1 |
| Mycoplasma-retentive filtration (0.1 µm) | check_circle Yes | cancel No | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP particulate compliance | check_circle USP <788> Method 1 | cancel Not specified | cancel Not specified |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle Available | cancel Fixed formulation | cancel Fixed formulation |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-DMEML-QB1X.
Supporting literature
Key peer-reviewed publications supporting ultra-filtered, microfluidics suitable media in organ-on-a-chip, microfluidic, and metabolic research applications.
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi:10.1126/science.123.3191.309
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Katt ME, et al. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol. 2016;4:12. doi:10.3389/fbioe.2016.00012
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

